NCT04067336 2025-11-10
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Kura Oncology, Inc.
Phase 1/2 Recruiting
Kura Oncology, Inc.
Ipsen
Xian-Janssen Pharmaceutical Ltd.
Janssen Korea, Ltd., Korea
Janssen Korea, Ltd., Korea
Zhejiang University